These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 18202013)

  • 1. Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects.
    Palmowski M; Huppert J; Ladewig G; Hauff P; Reinhardt M; Mueller MM; Woenne EC; Jenne JW; Maurer M; Kauffmann GW; Semmler W; Kiessling F
    Mol Cancer Ther; 2008 Jan; 7(1):101-9. PubMed ID: 18202013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squamous Cell Carcinoma Xenografts: Use of VEGFR2-targeted Microbubbles for Combined Functional and Molecular US to Monitor Antiangiogenic Therapy Effects.
    Baetke SC; Rix A; Tranquart F; Schneider R; Lammers T; Kiessling F; Lederle W
    Radiology; 2016 Feb; 278(2):430-40. PubMed ID: 26313618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular ultrasound imaging of early vascular response in prostate tumors irradiated with carbon ions.
    Palmowski M; Peschke P; Huppert J; Hauff P; Reinhardt M; Maurer M; Karger CP; Scholz M; Semmler W; Huber PE; Kiessling FM
    Neoplasia; 2009 Sep; 11(9):856-63. PubMed ID: 19724679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin αvβ3-targeted dynamic contrast-enhanced magnetic resonance imaging using a gadolinium-loaded polyethylene gycol-dendrimer-cyclic RGD conjugate to evaluate tumor angiogenesis and to assess early antiangiogenic treatment response in a mouse xenograft tumor model.
    Chen WT; Shih TT; Chen RC; Tu SY; Hsieh WY; Yang PC
    Mol Imaging; 2012; 11(4):286-300. PubMed ID: 22954145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo.
    Willmann JK; Lutz AM; Paulmurugan R; Patel MR; Chu P; Rosenberg J; Gambhir SS
    Radiology; 2008 Sep; 248(3):936-44. PubMed ID: 18710985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides.
    Willmann JK; Kimura RH; Deshpande N; Lutz AM; Cochran JR; Gambhir SS
    J Nucl Med; 2010 Mar; 51(3):433-40. PubMed ID: 20150258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic Modeling of Targeted Ultrasound Contrast Agents for Quantitative Assessment of Anti-Angiogenic Therapy: a Longitudinal Case-Control Study in Colon Cancer.
    Turco S; El Kaffas A; Zhou J; Lutz AM; Wijkstra H; Willmann JK; Mischi M
    Mol Imaging Biol; 2019 Aug; 21(4):633-643. PubMed ID: 30225758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-Dose Molecular Ultrasound Imaging with E-Selectin-Targeted PBCA Microbubbles.
    Spivak I; Rix A; Schmitz G; Fokong S; Iranzo O; Lederle W; Kiessling F
    Mol Imaging Biol; 2016 Apr; 18(2):180-90. PubMed ID: 26391990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.
    Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M
    Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent.
    Anderson CR; Hu X; Zhang H; Tlaxca J; Declèves AE; Houghtaling R; Sharma K; Lawrence M; Ferrara KW; Rychak JJ
    Invest Radiol; 2011 Apr; 46(4):215-24. PubMed ID: 21343825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional ultrasound molecular imaging of angiogenesis in colon cancer using a clinical matrix array ultrasound transducer.
    Wang H; Kaneko OF; Tian L; Hristov D; Willmann JK
    Invest Radiol; 2015 May; 50(5):322-9. PubMed ID: 25575176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can contrast-enhanced US with targeted microbubbles monitor the response to antiangiogenic therapies?
    Kruskal JB
    Radiology; 2008 Feb; 246(2):339-40. PubMed ID: 18227533
    [No Abstract]   [Full Text] [Related]  

  • 13. YM-359445, an orally bioavailable vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor, has highly potent antitumor activity against established tumors.
    Amino N; Ideyama Y; Yamano M; Kuromitsu S; Tajinda K; Samizu K; Hisamichi H; Matsuhisa A; Shirasuna K; Kudoh M; Shibasaki M
    Clin Cancer Res; 2006 Mar; 12(5):1630-8. PubMed ID: 16533791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-Targeted Microbubbles Specific to Integrin αVβ3 and Vascular Endothelial Growth Factor Receptor 2 for Ultrasonography Evaluation of Tumor Angiogenesis.
    Yuan HX; Wang WP; Wen JX; Lin LW; Exner AA; Guan PS; Chen XJ
    Ultrasound Med Biol; 2018 Jul; 44(7):1460-1467. PubMed ID: 29706409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RGD-Targeted Ultrasound Contrast Agent for Longitudinal Assessment of Hep-2 Tumor Angiogenesis In Vivo.
    Hu Q; Wang XY; Kang LK; Wei HM; Xu CM; Wang T; Wen ZH
    PLoS One; 2016; 11(2):e0149075. PubMed ID: 26862757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature.
    Warram JM; Sorace AG; Saini R; Umphrey HR; Zinn KR; Hoyt K
    J Ultrasound Med; 2011 Jul; 30(7):921-31. PubMed ID: 21705725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imaging.
    Deshpande N; Ren Y; Foygel K; Rosenberg J; Willmann JK
    Radiology; 2011 Mar; 258(3):804-11. PubMed ID: 21339349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound Molecular Imaging With BR55, a Predictive Tool of Antiangiogenic Treatment Efficacy in a Chemo-Induced Mammary Tumor Model.
    Helbert A; Von Wronski M; Colevret D; Botteron C; Padilla F; Bettinger T; Tardy I; Hyvelin JM
    Invest Radiol; 2020 Oct; 55(10):657-665. PubMed ID: 32229739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radionuclide imaging of tumor angiogenesis.
    Dijkgraaf I; Boerman OC
    Cancer Biother Radiopharm; 2009 Dec; 24(6):637-47. PubMed ID: 20025543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long residence time of ultrasound microbubbles targeted to integrin in murine tumor model.
    Jun HY; Park SH; Kim HS; Yoon KH
    Acad Radiol; 2010 Jan; 17(1):54-60. PubMed ID: 19815430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.